News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yüksel Ürün: Not all PD-L1 tests speak the same immune language
Yüksel Ürün/X
Apr 13, 2025, 13:50

Yüksel Ürün: Not all PD-L1 tests speak the same immune language

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Matthew D. Galsky et al, on X:

“Not all PD-L1 tests speak the same immune language.

Assay matters. Biology matters more.”

Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer 

Authors: Matthew D. Galsky, Sanjeev Mariathasan, et al.

Yüksel Ürün: Not all PD-L1 tests speak the same immune language

More posts featuring Yüksel Ürün.

biology cancer immunobiology Matthew D. Galsky OncoDaily Oncology PD-L1 Sanjeev Mariathasan urothelial cancer Yüksel Ürün
Special Coverage
Opinion
May 4, 2025, 11:29
STELLAR II trial at ESTRO 2025: Immunotherapy Combined with Radiotherapy and Chemotherapy Reduces the Need for Surgery in Locally Advanced Rectal Cancer
Blog
May 4, 2025, 11:26
Collaboration between National Societies and Patients can Strengthen Advocacy - ESTRO
Blog
May 4, 2025, 11:14
Marie-Catherine Vozenin Honored with Claudius Regaud Award at ESTRO 2025
Blog
May 4, 2025, 11:13
Princess Dina Mired: A true trailblazer in Pediatric Oncology by Carlos Rodriguez-Galindo
Blog
May 4, 2025, 11:11
Ina Jürgenliemk-Schulz Receives Iridium 192 Award at ESTRO 2025
Societies
May 4, 2025, 11:03
ASCO Urges Lawmakers to Protect Federal Funding for Cancer Research and Prevention
Blog
May 4, 2025, 10:59
Sarah Barrett: A great and busy start to ESTRO25
Blog
May 4, 2025, 10:57
Joanna Metzner-Sadurski: Proud of Ruiling Yuan for Moderating 2025 COP Webinar on Oncology Advocacy
Blog
May 4, 2025, 10:46
Theresa O Donovan: RTTs Experiences and Perceptions of Providing Support to Patients with Acute Psychosocial Distress
Blog
May 4, 2025, 10:39
Andrew Loblaw: 20 year Data Propensity-based analysis of LDR vs HDR boost
Blog
May 4, 2025, 10:29
Enar Recalde: Radiotherapy for Merkel cell carcinoma at ESTRO2025
Blog
May 4, 2025, 10:21
Piet Ost: Can Durvalumab and SBRT improve outcomes in Oligorecurrent Prostate Cancer?